[CLSTR]
< Back to situation

[REVISION HISTORY]

Market forecast reports expand across sectors

Updated 2 times since CLSTR started tracking revisions of this situation.

What changed

2026-08-05 17:13 UTC → 2026-08-07 15:04 UTC · added removed

In late July 2026 a wave of market‑research publications projected robust growth for a wide range of industries, from crop‑insurance and genomics to elevators, infusion pumps, semiconductor metrology and Indonesia’s mobile‑services market. The forecasts cited climate‑related risks, AI, IoT and 5G adoption as primary drivers. Around the same time, Japanese distributor SEMABIZ announced two health‑care‑focused reports: a global biomarkers market outlook to 2031 and a pulse‑lavage market projection to 2033. The biomarkers report projected a rise from US$67.95 billion in 2026 to US$112.1 billion by 2031, driven by AI‑enabled digital pathology and precision‑medicine uptake. The pulse‑lavage study forecast the market to more than double by 2033, citing growing demand for infection‑control solutions in orthopedic, trauma and cardiovascular surgery. On 3 August 2026, Fortune Business Insights released broader forecasts for the global biomarkers market (projected US$244 billion by 2034) and the proteomics market (US$67.6 billion by 2031). Both reports highlighted extensive product launches, strategic partnerships and M&A activity among leading life‑science firms, reinforcing the trend of increasingly detailed, technology‑driven market analyses across commercial and medical sectors. Data Bridge Market Research added forecasts for the Spare Parts Management market, valuing it at US$1.20 billion in 2025 and projecting US$2.62 billion by 2033 (CAGR 10.3%). It also projected the functional genomics market to grow from US$7.28 billion in 2025 to US$16.89 billion by 2033 (CAGR 11.1%). These additions broaden A further report released on 6 August 2026 projected the sectoral coverage, underscoring global Anatomic Pathology market to rise from US$8.9 billion in 2026 to US$14.5 billion by 2031 (CAGR 10.2%) and the ongoing expansion Companion Diagnostics market to grow from US$6.31 billion to US$11.57 billion over the same period (CAGR 12.9%). Growth is attributed to precision‑medicine adoption, targeted oncology therapies and expanding use of specialized, data‑rich market‑forecast research that informs investors, manufacturers PCR and policymakers. next‑generation sequencing, extending the pattern of detailed, technology‑driven market outlooks in the life‑science sector.

Versions

  1. 2026-08-07 15:04 UTC Market forecast reports expand across sectors
  2. 2026-08-05 17:13 UTC Market forecast reports expand across sectors
  3. 2026-08-05 05:12 UTC Market forecast reports expand across sectors

Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.